A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients with Extensive Small-Cell Lung Cancer

Background: Small-cell lung cancer (SCLC), a variant of lung cancer marked by early metastases, accounts for 13% of all lung cancers diagnosed in US. Despite high response rates to treatment, it is an aggressive disease with a median survival of 9–11 months for patients with extensive stage (EX-SCLC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Huang, Chao H., Wick, Jo A., Sittampalam, Gurusingham Sitta, Nirmalanandhan, Victor Sanjit, Ganti, Apar Kishor, Neupane, Prakash C., Williamson, Stephen K., Godwin, Andrew K., Schmitt, Sarah, Smart, Nora J., Spencer, Sarah, Van Veldhuizen, Peter J.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2014
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4196518/
https://ncbi.nlm.nih.gov/pubmed/25353007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2014.00271
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados